HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Simon P Kim Selected Research

Therapeutics

1/2022Radical cystectomy versus trimodality therapy for muscle-invasive urothelial carcinoma of the bladder.
11/2021Radical prostatectomy versus external beam radiation therapy for high-grade, clinically localized prostate cancer: Emulation of a target clinical trial.
11/2019A Cost-effectiveness Analysis of Systemic Therapy for Metastatic Hormone-sensitive Prostate Cancer.
10/2018Comparative Effectiveness of Local and Systemic Therapy for T4 Prostate Cancer.
5/2017Comparative Effectiveness of Surgical Treatments for Small Renal Masses.
11/2016National sociodemographic disparities in the treatment of high-risk prostate cancer: Do academic cancer centers perform better than community cancer centers?
9/2016Disparities in Treatment of Patients With High-risk Prostate Cancer: Results From a Population-based Cohort.
7/2015Patterns of Declining Use and the Adverse Effect of Primary Androgen Deprivation on All-cause Mortality in Elderly Men with Prostate Cancer.
4/2015Temporal trends and factors associated with systemic therapy after cytoreductive nephrectomy: an analysis of the National Cancer Database.
2/2015The impact of targeted therapy on management of metastatic renal cell carcinoma: trends in systemic therapy and cytoreductive nephrectomy utilization.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Simon P Kim Research Topics

Disease

40Neoplasms (Cancer)
01/2022 - 11/2007
32Prostatic Neoplasms (Prostate Cancer)
01/2022 - 07/2008
16Renal Cell Carcinoma (Grawitz Tumor)
01/2018 - 06/2011
15Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 06/2012
8Carcinoma (Carcinomatosis)
01/2022 - 08/2012
6Margins of Excision
04/2021 - 07/2014
4Neoplasm Metastasis (Metastasis)
01/2021 - 09/2011
4Chronic Renal Insufficiency
05/2014 - 07/2012
3Non-Muscle Invasive Bladder Neoplasms
11/2021 - 08/2014
3Sepsis (Septicemia)
02/2015 - 06/2012
2Disease Progression
06/2016 - 09/2012
2Surgical Wound Infection
10/2014 - 06/2012
2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
02/2014 - 11/2009
2Urinary Incontinence
01/2014 - 05/2008
2Ureteral Obstruction
02/2008 - 11/2007
1Urinary Retention
01/2022
1Cystitis
01/2022
1Adenocarcinoma
11/2021
1Weight Loss (Weight Reduction)
01/2019
1Malnutrition (Nutritional Deficiencies)
01/2019
1Mental Disorders (Mental Disorder)
01/2018
1Adrenocortical Carcinoma
01/2017
1Intraoperative Complications
01/2017
1Stress Urinary Incontinence
01/2017
1Lymphatic Metastasis
03/2015
1Erectile Dysfunction
01/2014
1Urolithiasis
07/2013
1Hypothermia
03/2013
1Ischemia
03/2013
1Solitary Kidney
02/2013
1Pressure Ulcer (Bedsore)
06/2012
1Embolism (Embolus)
06/2012
1Venous Thrombosis (Deep-Vein Thrombosis)
06/2012
1Chronic Disease (Chronic Diseases)
11/2009
1Infections
05/2008
1Hydronephrosis
02/2008
1Retroperitoneal Fibrosis
11/2007

Drug/Important Bio-Agent (IBA)

8Prostate-Specific Antigen (Semenogelase)IBA
01/2021 - 06/2012
4AndrogensIBA
11/2021 - 01/2014
2amsonic acid (DAS)IBA
01/2022 - 01/2021
2Dihydrotachysterol (AT 10)IBA
11/2011 - 09/2011
1Biomarkers (Surrogate Marker)IBA
10/2020
1Docetaxel (Taxotere)FDA Link
11/2019
1abirateroneIBA
11/2019
1Abiraterone AcetateIBA
11/2019
1Hormones (Hormone)IBA
11/2019
1Serum AlbuminIBA
01/2019
1SolutionsIBA
10/2014
1Cisplatin (Platino)FDA LinkGeneric
05/2014
1Oxidoreductases (Dehydrogenase)IBA
02/2014
1Pregnenolone Carbonitrile (PCN)IBA
07/2013
1sulindac sulfone (exisulind)IBA
08/2012
1A 19IBA
07/2012
1Sunitinib (Sutent)FDA Link
09/2011
1CreatinineIBA
02/2008

Therapy/Procedure

25Nephrectomy
01/2019 - 06/2011
19Prostatectomy (Retropubic Prostatectomy)
01/2022 - 07/2008
19Cystectomy
01/2022 - 06/2012
18Therapeutics
01/2022 - 10/2013
12Radiotherapy
01/2022 - 07/2008
7Lymph Node Excision (Lymph Node Dissection)
01/2022 - 06/2014
5Drug Therapy (Chemotherapy)
12/2021 - 11/2009
4Length of Stay
01/2017 - 06/2012
3Blood Transfusion (Blood Transfusions)
01/2022 - 05/2014
3Urinary Diversion (Ileal Conduit)
01/2017 - 12/2011
2Neoadjuvant Therapy
12/2021 - 05/2014
2Brachytherapy
01/2021 - 07/2014
2Esophagectomy
01/2019 - 02/2015
2Aftercare (After-Treatment)
01/2018 - 06/2012
2Adrenalectomy
01/2017 - 09/2011
2Terminal Care (Care, Terminal)
02/2015 - 08/2014
2Stents
02/2008 - 11/2007
1Continuity of Patient Care
01/2022
1Conformal Radiotherapy
01/2022
1Simple Mastectomy
10/2020
1Modified Radical Mastectomy (Mastectomy, Modified)
10/2020
1Nephroureterectomy
05/2020
1Adjuvant Chemotherapy
05/2020
1Particle Accelerators
10/2019
1Pancreatectomy
01/2019
1Pneumonectomy (Lung Volume Reduction)
01/2019
1Hysterectomy
01/2019
1Gastrectomy
01/2019
1Colectomy
01/2019
1Suburethral Slings (Tension-Free Vaginal Tape)
01/2017
1Hospice Care (Care, Bereavement)
02/2015
1Adjuvant Radiotherapy
10/2013
1Splenectomy
09/2013
1Decompression
07/2013
1Warm Ischemia
03/2013
1Punctures
06/2012
1Artificial Urinary Sphincter
05/2008